IMMUSOFT Trademark

Trademark Overview

On Wednesday, September 19, 2012, a trademark application was filed for IMMUSOFT with the United States Patent and Trademark Office. The USPTO has given the IMMUSOFT trademark a serial number of 85732688. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 2, 2024. This trademark is owned by Immusoft Corporation. The IMMUSOFT trademark is filed in the Pharmaceutical Products category with the following description:

Gene therapy products, namely, genetically engineered tissues for transplant purposes
immusoft

General Information

Serial Number85732688
Word MarkIMMUSOFT
Filing DateWednesday, September 19, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 2, 2024
Registration Number4373723
Registration DateTuesday, July 23, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 22, 2013

Trademark Statements

Goods and ServicesGene therapy products, namely, genetically engineered tissues for transplant purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 2, 2024
Primary Code005
First Use Anywhere DateSaturday, August 1, 2009
First Use In Commerce DateTuesday, January 1, 2013

Trademark Owner History

Party NameImmusoft Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 981211172
Party NameImmusoft Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 981211172
Party NameImmusoft Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 981211172

Trademark Events

Event DateEvent Description
Friday, February 2, 2024CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, July 23, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, August 14, 2018NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Tuesday, August 14, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, August 13, 2018TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Friday, August 10, 2018POST REGISTRATION ACTION MAILED - SEC. 8
Friday, July 27, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, July 24, 2018TEAS SECTION 8 RECEIVED
Monday, July 23, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 23, 2013REGISTERED-PRINCIPAL REGISTER
Thursday, June 20, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, June 19, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, June 18, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, June 17, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 17, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 10, 2013ASSIGNED TO LIE
Friday, June 7, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 17, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 17, 2013NON-FINAL ACTION E-MAILED
Wednesday, April 17, 2013SU - NON-FINAL ACTION - WRITTEN
Tuesday, April 16, 2013STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 20, 2013USE AMENDMENT FILED
Monday, April 15, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 20, 2013TEAS STATEMENT OF USE RECEIVED
Tuesday, March 19, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 22, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 22, 2013PUBLISHED FOR OPPOSITION
Wednesday, January 2, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 11, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, December 9, 2012ASSIGNED TO EXAMINER
Saturday, September 22, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 22, 2012NEW APPLICATION ENTERED

Related Keywords

immusoft tissues transplant purposes engineered genetically therapy products namely gene